SRXN1 and colonic neoplasm: Furthermore, flow cytometry cell death assays based on Annexin V-FITC/PI staining revealed that increased Prx (I, II, III) expression resulted in a decline in colon cancer cell death after Srx depletion and TNFα/CHX treatment (Fig. 4H).